JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB30470

Anti-CD45 antibody [F10-89-4] - Hematopoietic Stem Cell Marker

5

(1 Review)

|

(21 Publications)

Anti-CD45 antibody [F10-89-4] - Hematopoietic Stem Cell Marker (ab30470) is a mouse monoclonal antibody detecting CD45 in Flow Cytometry, IHC-P, ICC/IF. Suitable for Human.

- Over 10 publications
- Trusted since 2006

View Alternative Names

CD45, PTPRC, Receptor-type tyrosine-protein phosphatase C, Leukocyte common antigen, T200, L-CA

2 Images
Flow Cytometry - Anti-CD45 antibody [F10-89-4] - Hematopoietic Stem Cell Marker (AB30470)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-CD45 antibody [F10-89-4] - Hematopoietic Stem Cell Marker (AB30470)

Overlay histogram showing Jurkat (Human T cell leukemia cell line from peripheral blood) cells stained with ab30470 (red line). The cells were fixed with 4% paraformaldehyde (10 minutes) and incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab30470, 1 μg/1 x 106 cells) for 30 minutes at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 minutes at 22°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1 μg/1 x 106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in Jurkat cells fixed with 80% methanol (5 minutes) used under the same conditions.

Please note that Abcam do not have any data for use of this antibody on non-fixed cells. We welcome any customer feedback.

Flow Cytometry - Anti-CD45 antibody [F10-89-4] - Hematopoietic Stem Cell Marker (AB30470)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-CD45 antibody [F10-89-4] - Hematopoietic Stem Cell Marker (AB30470)

Flow cytometry staining of human whole blood with ab30470 (right) or mouse IgG2aκ; (ab18413) isotype (left). Red blood cells of 200 μL blood were lysed, then cells were incubated for 30 min on ice in 1x PBS containing 10 μg/ml human IgG and 10 % normal goat serum to block FC receptors and non-specific protein-protein interaction followed by the antibody (ab30470) or mouse IgG2aκ; (ab18413) isotype (1x106 in 100 μL at 0.2 μg/ml) for 30 min on ice.

The secondary antibody Goat anti-mouse IgG H&L (Alexa Fluor ® 488, pre-adsorbed) (ab150117) was used at 1/2000 dilution for 30 min on ice.

Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 530/30 bandpass filter. Events were gated on alive cells.

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

F10-89-4

Isotype

IgG2a

Carrier free

No

Reacts with

Human

Applications

Flow Cyt, IHC-P, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

Clone F10-89-4 reacts with all forms of CD45 expressed by all haematopoietic cells, except erythrocytes, having a higher level of expression on lymphocytes than on granulocytes.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1-5 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/10 - 1/50", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg2c-kappa-monoclonal-18c8bc7ad10-isotype-control-ab170191'>ab170191</a> - Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "5-10 µg/mL", "ICCIF-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-CD45 antibody [F10-89-4] - Hematopoietic Stem Cell Marker (ab30470) is a mouse monoclonal antibody and is validated for use in Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

Trusted by the scientific community
Anti-CD45 [F10-89-4] - Hematopoietic Stem Cell Marker (ab30470) was first used in a scientific publication in 2006 and has been cited over 10 times in peer-reviewed journals.

Other related products
We have a range of other formats of antibody clone [F10-89-4] also available for your convenience: ab30470, Alexa Fluor® 488 - ab197730, Carrier free - ab230296

Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com

Properties and storage information

Form
Liquid
Purification technique
Affinity purification
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD45 also known as Protein tyrosine phosphatase receptor type C (PTPRC) is a transmembrane glycoprotein with a molecular mass ranging between 180-240 kDa depending on its isoform. It is expressed on the surface of almost all hematopoietic cells except for mature erythrocytes and platelets. CD45 has a critical role in regulating antigen receptor signaling by modifying kinases involved in signal transduction and it is essential in lymphocyte development and activation. Because of its broad expression on immune cells CD45 is a valuable marker for differentiating various immune cell types in assays like flow cytometry and immunohistochemistry (IHC) often referred to as CD45 stain.
Biological function summary

CD45 acts by regulating tyrosine phosphorylation in the immune cell signaling context participating directly in signal transduction. It functions by dephosphorylating specific phosphotyrosine residues on various proteins modulating the signaling threshold required for lymphocyte activation. Although not known to be part of a protein complex CD45 itself shows isoform variation that associates with specific immune cell types impacting their function. Importantly CD45 interacts with multiple signaling molecules to affect cell growth and differentiation.

Pathways

Scientists associate CD45 with signaling pathways such as the T-cell receptor (TCR) and B-cell receptor (BCR) signaling. CD45 modulates the activity of Src family kinases important elements in these pathways making it essential for effective immune response and tolerance. Furthermore interactions between CD45 and proteins like Lck in T-cells or Lyn in B-cells highlight its pivotal role in executing its signaling functions.

Scientists often link CD45 to immune-related conditions including autoimmunity and leukemia. In autoimmune diseases altered CD45 expression or activity can disrupt normal immune function contributing to pathogenesis. In leukemia CD45 expression levels can assist in disease classification and prognosis as it interacts with proteins involved in cell cycle regulation. The anti-CD45 antibodies can provide diagnostic and therapeutic avenues highlighting their utility in disease management.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Protein tyrosine-protein phosphatase required for T-cell activation through the antigen receptor (PubMed : 35767951). Acts as a positive regulator of T-cell coactivation upon binding to DPP4. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits and dephosphorylates SKAP1 and FYN. Dephosphorylates LYN, and thereby modulates LYN activity (By similarity). Interacts with CLEC10A at antigen presenting cell-T cell contact; CLEC10A on immature dendritic cells recognizes Tn antigen-carrying PTPRC/CD45 receptor on effector T cells and modulates T cell activation threshold to limit autoreactivity.. (Microbial infection) Acts as a receptor for human cytomegalovirus protein UL11 and mediates binding of UL11 to T-cells, leading to reduced induction of tyrosine phosphorylation of multiple signaling proteins upon T-cell receptor stimulation and impaired T-cell proliferation.
See full target information PTPRC

Publications (21)

Recent publications for all applications. Explore the full list and refine your search

Journal of neuroinflammation 22:119 PubMed40275379

2025

A 3D human iPSC-derived multi-cell type neurosphere system to model cellular responses to chronic amyloidosis.

Applications

Unspecified application

Species

Unspecified reactive species

Stefan Wendt,Ada J Lin,Sarah N Ebert,Declan J Brennan,Wenji Cai,Yanyang Bai,Da Young Kong,Stefano Sorrentino,Christopher J Groten,Christopher Lee,Jonathan Frew,Hyun B Choi,Konstantina Karamboulas,Mathias Delhaye,Ian R Mackenzie,David R Kaplan,Freda D Miller,Brian A MacVicar,Haakon B Nygaard

Cells 14: PubMed39791754

2025

Trying to Kill a Killer; Impressive Killing of Patient Derived Glioblastoma Cultures Using NK-92 Natural Killer Cells Reveals Both Sensitive and Highly Resistant Glioblastoma Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jane Yu,Hyeon Joo Kim,Jordyn Reinecke,James Hucklesby,Tennille Read,Akshata Anchan,Catherine E Angel,Euan Scott Graham

Gut microbes 16:2402543 PubMed39288239

2024

ADP-heptose attenuates -induced dendritic cell activation.

Applications

Unspecified application

Species

Unspecified reactive species

Theresa Neuper,Tobias Frauenlob,Hieu-Hoa Dang,Peter W Krenn,Gernot Posselt,Christof Regl,Nikolaus Fortelny,Veronika Schäpertöns,Michael S Unger,Gunda Üblagger,Daniel Neureiter,Iris Mühlbacher,Michael Weitzendorfer,Franz Singhartinger,Klaus Emmanuel,Christian G Huber,Silja Wessler,Fritz Aberger,Jutta Horejs-Hoeck

Communications biology 7:1041 PubMed39179795

2024

PGRMC2 and HLA-G regulate immune homeostasis in a microphysiological model of human maternal-fetal membrane interface.

Applications

Unspecified application

Species

Unspecified reactive species

Ryan C V Lintao,Lauren S Richardson,Ananth Kumar Kammala,Jenieve Chapa,Dianne Aster Yunque-Yap,Kamil Khanipov,George Golovko,Leslie Michelle M Dalmacio,Ramkumar Menon

Lab on a chip 24:1727-1749 PubMed38334486

2024

Endocrine-disrupting compounds and their impact on human placental function: evidence from placenta organ-on-chip studies.

Applications

Unspecified application

Species

Unspecified reactive species

Manuel S Vidal,Lauren S Richardson,Ananth Kumar Kammala,Sungjin Kim,Po Yi Lam,Rahul Cherukuri,Tilu Jain Thomas,Mohammed Bettayeb,Arum Han,Ivan Rusyn,Ramkumar Menon

American journal of reproductive immunology (New York, N.Y. : 1989) 90:e13770 PubMed37766409

2023

Modeling an ascending infection by Ureaplasma parvum and its cell signaling and inflammatory response at the feto-maternal interface.

Applications

Unspecified application

Species

Unspecified reactive species

Giovana Fernanda Cosi Bento,Lauren S Richardson,Márcia Guimarães da Silva,Ourlad Alzeus G Tantengco,Ramkumar Menon

Neurology(R) neuroimmunology & neuroinflammation 10: PubMed37236806

2023

Immunohistologic Features of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic Thrombocytopenia.

Applications

Unspecified application

Species

Unspecified reactive species

Thomas Geeraerts,Céline Guilbeau-Frugier,Cédric Garcia,Vincent Memier,Nicolas Raposo,Fabrice Bonneville,Céline Gales,Jean Darcourt,Sophie Voisin,Agnès Ribes,Marie Piel-Julian,Fanny Bounes,Jean François Albucher,Franck-Emmanuel Roux,Jacques Izopet,Norbert Telmon,Jean Marc Olivot,Pierre Sié,Jan Bauer,Bernard Payrastre,Roland S Liblau

Science advances 9:eadg0654 PubMed37115931

2023

Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Jia Chen,Guan-Nan Li,Xian-Jing Li,Lin-Xing Wei,Min-Jie Fu,Zhou-Li Cheng,Zhen Yang,Gui-Qi Zhu,Xu-Dong Wang,Cheng Zhang,Jin-Ye Zhang,Yi-Ping Sun,Hexige Saiyin,Jin Zhang,Wei-Ren Liu,Wen-Wei Zhu,Kun-Liang Guan,Yue Xiong,Yong Yang,Dan Ye,Lei-Lei Chen

Journal of immunology (Baltimore, Md. : 1950) 210:1437-1446 PubMed36920387

2023

A Microphysiological Device to Model the Choriodecidual Interface Immune Status during Pregnancy.

Applications

Unspecified application

Species

Unspecified reactive species

Lauren Richardson,Enkhtuya Radnaa,Ryan C V Lintao,Rheanna Urrabaz-Garza,Ruhi Maredia,Arum Han,Jiaren Sun,Ramkumar Menon

Glia 71:1522-1535 PubMed36825534

2023

Complement receptor 1 is expressed on brain cells and in the human brain.

Applications

Unspecified application

Species

Unspecified reactive species

Nikoleta Daskoulidou,Bethany Shaw,Megan Torvell,Lewis Watkins,Emma L Cope,Sarah M Carpanini,Nicholas D Allen,B Paul Morgan
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com